Name

Seahorse Bioscience

Legal name

Seahorse Bioscience

Website

https://seahorsebio.com

Company type

Private

Founded year

2000

Operating status

Acquired

Headcount range

51–100 employees

Ownership category

akta.pro rank

Headquarters

HQ city

North Billerica

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Cell Analysis Instruments and Consumables: Sale of Seahorse XF instruments and associated assay plates, reagents, and consumables for bioenergetics research.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Seahorse Bioscience designs, manufactures, and sells the Seahorse XF Platform, a real-time bioenergetics analysis system that measures oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in live cells. The company also provides associated assay kits, reagents, and consumables for cell metabolism, cancer biology, cardiovascular research, immunology, neurobiology, stem cell biology, and drug discovery applications. Now part of Agilent Technologies' Cell Analysis division, the platform is sold alongside complementary instruments and labware for biological research and drug development.

Product overview

Seahorse Bioscience, now part of Agilent, offers the Seahorse XF Platform as its core product for real-time cell bioenergetics analysis. The platform enables researchers to measure oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in live cells, supporting applications across cell metabolism, cancer biology, cardiovascular research, immunology, neurobiology, stem cell biology, and drug discovery. The technology is used in conjunction with Agilent's cell analysis instruments and tools for measuring cell health, proliferation, migration, and metabolism.

Differentiator

Problem solved

Functional benefit

Products and services

• Agilent Seahorse XF Platform Real-time bioenergetics analysis platform that measures oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in live cells for academic research institutions, pharmaceutical companies, biotechnology firms, and contract research organizations conducting cell metabolism and drug discovery studies.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Thermo Fisher Scientific: Largest life-sciences analytical instruments and cell-analysis incumbent with broad portfolios spanning flow cytometry, microplate readers, and cell metabolism assays. Directly comparable as the dominant alternative to Agilent/Seahorse in cell-based analytical instrumentation serving pharma and academic research customers.
• Sartorius: Major bioprocessing and cell-analysis provider serving pharma manufacturing and biotech research with cell-line development and analytical platforms. Comparable in serving cell biology research customers, particularly in upstream bioprocess and cell therapy workflows.
• PerkinElmer: Diversified life-sciences and analytical instruments player with cell imaging, microplate, and reagent offerings. Competes with Agilent/Seahorse in life-science research and drug discovery instrumentation budgets.
• Bruker: Manufacturer of advanced analytical instruments (mass spectrometry, NMR, microscopy) with growing cell-analysis solutions. Comparable as an analytical-instrument vendor selling into the same academic and pharma research customers.
• Beckman Coulter Life Sciences (Danaher): Provides flow cytometry, cell sorting, and particle characterization instruments for research and clinical labs. Comparable as a cell-analysis instrumentation peer with overlapping customers in pharma/biotech research.
• Merck KGaA (MilliporeSigma): Life-science tools and reagents giant with cell biology, bioprocessing, and lab instrumentation offerings. Comparable as a broad incumbent serving cell metabolism, cell health, and drug discovery research workflows overlapping with Seahorse XF customers.

Direct peers

• Molecular Devices (Danaher): Specializes in microplate readers, high-content imaging, and cell-based assay instruments used in drug discovery and academic research. Overlaps directly with Seahorse XF in live-cell functional measurement workflows within pharma/biotech screening labs.
• Promega: Provides cell-based luminescent and fluorescent assays, including metabolism and viability kits, sold into pharma and academic research. Overlaps with Seahorse XF in cell health, cytotoxicity, and metabolic phenotype readouts for drug discovery.
• BMG LABTECH: Specializes in microplate readers with cell metabolism and live-cell kinetic readouts, including oxygen consumption and pH sensing modes. Directly competes with the Seahorse XF platform in metabolic and cell-based assay workflows.

Emerging players

• Bio-Techne: Offers life-science research tools including reagents, proteomics, and cell/gene therapy workflow solutions. Comparable as a research-tools provider with growing cell-analysis offerings relevant to the same pharma/biotech buyer profile as Seahorse.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/SeahorseBio
• Facebookfacebook.com/21073314560734
• LinkedInlinkedin.com/company/seahorse-bioscience

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds5 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Seahorse Bioscience